Skip navigation


Company: Gilead Sciences Inc

Gilead Sciences Inc : [GILD  Loading...      ()   ]
 | Source: The Associated Press
Shares of some top biotechnology companies are mixed at 1 p.m.:
 | Source: The Associated Press
Shares of some top biotechnology companies are mixed at 10 a.m.:
Thursday, 24 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are up at 1 p.m.:
Wednesday, 23 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are mixed at 10 a.m.:
Monday, 21 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are up at 1 p.m.:
Monday, 21 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are up at 10 a.m.:
Friday, 18 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are down at 10 a.m.:
Thursday, 17 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies were down at the close of trading:
Thursday, 17 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are down at 1 p.m.:
Thursday, 17 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are down at 10 a.m.:
Wednesday, 16 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are mixed at 10 a.m.:
Tuesday, 15 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies were mixed at the close of trading:
Monday, 14 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are mixed at 10 a.m.:
Friday, 11 May 2012 | Source: The Associated Press
Shares of some top biotechnology companies are up at 1 p.m.:
Friday, 11 May 2012 | Source: The Associated Press
Gilead Sciences Inc. received a positive endorsement Thursday from a panel of FDA advisors for one of its HIV treatments and will likely receive another good review Friday, according to analysts.
Next
Posts |  COMPANY : Gilead Sciences Inc
26 Apr 2012
Check out which companies are making headlines after-the-bell Thursday: ... Read More
24 Apr 2012
Posted By:Adam FeuersteinCNBC Stock Blog
Vertex Pharmaceuticals is expected to report strong initial sales of its cystic fibrosis drug Kalydeco on Thursday as investors shift their attention away from the waning performance of the company's hepatitis C drug Incivek... Read More
19 Apr 2012
Earlier in the trading session, eBay shares were up as much as 16.6 percent, their best intraday gain since Oct... Read More
19 Apr 2012
Human Genome Sciences is one of the reasons the NYSE Arca Biotech Index is having its best day since December 2010... Read More
9 Apr 2012
Posted By:Adam FeuersteinCNBC Stock Blog
The Spectrum Pharmaceuticals growth party is over... Read More
VIDEO | COMPANIES : Gilead Sciences Inc
Ireland has made significant cuts and strides in its efforts to tackle its own debt crisis. How different is Ireland fro...
Kathy Lien, Director of Global Research and Analysis (Director of Currency Research), GFT Forex says that ECB will intro...
Neil Atkinson, director of energy research & analysis at Datamonitor, told CNBC, "The negotiations have started quite pr...
Representative Dan Lipinski, (D-IL), discusses the government's efforts to fund potential start-ups with tax dollars thr...
Discussing whether the government's efforts for public innovation will help grow the economy, with Dedric Carter, Nation...


Current DateTime: 02:05:38 24 May 2012
LinksList Documentid: 23188555



Current DateTime: 02:05:38 24 May 2012
LinksList Documentid: 23188557

Current DateTime: 05:24:27 25 May 2012
LinksList Documentid: 29778428

Current DateTime: 02:05:35 24 May 2012
LinksList Documentid: 29779196

Current DateTime: 12:59:34 25 May 2012
LinksList Documentid: 29779197

Current DateTime: 08:53:36 25 May 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters